XML 84 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) (USD $)
3 Months Ended 12 Months Ended
Dec. 31, 2013
Sep. 30, 2013
Jun. 30, 2013
Mar. 31, 2013
Dec. 31, 2012
Sep. 30, 2012
Jun. 30, 2012
Mar. 31, 2012
Dec. 31, 2013
Item
segment
Dec. 31, 2012
Item
Dec. 31, 2011
Item
Net Income (Loss) Per Common Share                      
Numerator: Net income (loss) $ 41,801,000 $ 6,514,000 $ 478,000 $ (5,480,000) $ (3,704,000) $ (1,495,000) $ (15,780,000) $ (8,804,000) $ 43,313,000 $ (29,781,000) $ 70,726,000
Denominator for basic net income (loss) per share (in shares)                 56,736,009 55,892,563 54,562,820
Net effect of dilutive common shares (in shares)                     1,527,000
Denominator for diluted net income (loss) per share: (in shares)                 57,543,979 55,892,563 56,089,796
Basic net income (loss) per share (in dollars per share) $ 0.73 $ 0.11 $ 0.01 $ (0.10) $ (0.07) $ (0.03) $ (0.28) $ (0.16) $ 0.76 $ (0.53) $ 1.30
Diluted net income (loss) per share (in dollars per share) $ 0.72 $ 0.11 $ 0.01 $ (0.10) $ (0.07) $ (0.03) $ (0.28) $ (0.16) $ 0.75 $ (0.53) $ 1.26
Total number of antidilutive outstanding common shares excluded from the net income (loss) per share computation (in shares)                 4,800,000 6,000,000 1,500,000
Segment Information                      
Number of operating segments                 1    
Concentration of Risk                      
Number of distributors                 3 3 3
Accounts receivable related to product sales 11,451,000       3,614,000       11,451,000 3,614,000 4,400,000
Accounts receivable balances related to royalties 7,200,000       5,100,000       7,200,000 5,100,000  
Santarus
                     
Concentration of Risk                      
Accounts receivable balances related to royalties $ 6,400,000       $ 4,400,000       $ 6,400,000 $ 4,400,000  
Supplier concentration risk | Gralise
                     
Concentration of Risk                      
Number of third-party suppliers for the supply of gabapentin                 2    
Product shipments | Customer concentration risk | Distributor one
                     
Concentration of Risk                      
Percentage of concentration risk                 35.00% 39.00% 46.00%
Product shipments | Customer concentration risk | Distributor two
                     
Concentration of Risk                      
Percentage of concentration risk                 37.00% 40.00% 32.00%
Product shipments | Customer concentration risk | Distributor three
                     
Concentration of Risk                      
Percentage of concentration risk                 21.00% 14.00% 17.00%
Product sales related accounts receivable | Credit concentration risk | Distributor one
                     
Concentration of Risk                      
Percentage of concentration risk                 23.00% 46.00% 54.00%
Product sales related accounts receivable | Credit concentration risk | Distributor two
                     
Concentration of Risk                      
Percentage of concentration risk                 35.00% 42.00% 29.00%
Product sales related accounts receivable | Credit concentration risk | Distributor three
                     
Concentration of Risk                      
Percentage of concentration risk                 34.00% 5.00% 9.00%